Literature DB >> 19924738

Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.

Wen-Jing Song1, Jin-Zhi Du, Tian-Meng Sun, Pei-Zhuo Zhang, Jun Wang.   

Abstract

An efficient and safe delivery system for small interfering RNA (siRNA) is required for clinical application of RNA interfering therapeutics. Polyethyleneimine (PEI)-capped gold nanoparticles (AuNPs) are successfully manufactured using PEI as the reductant and stabilizer, which bind siRNA at an appropriate weight ratio by electrostatic interaction and result in well-dispersed nanoparticles with uniform structure and narrow size distribution. With siRNA binding, PEI-capped AuNPs induce more significant and enhanced reduction in targeted green fluorescent protein expression in MDA-MB-435s cells, though more internalized PEI/siRNA complexes in cells are evidenced by confocal laser scanning microscopy observation and fluorescence-activated cell sorting analyses. PEI-capped AuNPs/siRNA targeting endogenous cell-cycle kinase, an oncogene polo-like kinase 1 (PLK1), display significant gene expression knockdown and induce enhanced cell apoptosis, whereas it is not obvious when the cells are treated with PLK1 siRNA using PEI as the carrier. Without exhibiting cellular toxicity, PEI-capped AuNPs appear to be suitable as a potential carrier for intracellular siRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19924738     DOI: 10.1002/smll.200901513

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  52 in total

1.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

Authors:  Hyejung Mok; Omid Veiseh; Chen Fang; Forrest M Kievit; Freddy Y Wang; James O Park; Miqin Zhang
Journal:  Mol Pharm       Date:  2010-09-14       Impact factor: 4.939

2.  Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections.

Authors:  Fang-Yi Su; Jasmin Chen; Hye-Nam Son; Abby M Kelly; Anthony J Convertine; T Eoin West; Shawn J Skerrett; Daniel M Ratner; Patrick S Stayton
Journal:  Biomater Sci       Date:  2018-06-25       Impact factor: 6.843

Review 3.  Delivery technologies for cancer immunotherapy.

Authors:  Rachel S Riley; Carl H June; Robert Langer; Michael J Mitchell
Journal:  Nat Rev Drug Discov       Date:  2019-03       Impact factor: 84.694

4.  Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction.

Authors:  Lorenzo Berti; Temesgen Woldeyesus; Yuanpei Li; Kit S Lam
Journal:  Langmuir       Date:  2010-11-03       Impact factor: 3.882

Review 5.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 6.  Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.

Authors:  Devan L Puhl; Anthony R D'Amato; Ryan J Gilbert
Journal:  Brain Res Bull       Date:  2019-06-05       Impact factor: 4.077

7.  Systematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applications.

Authors:  Pratap C Naha; Peter Chhour; David P Cormode
Journal:  Toxicol In Vitro       Date:  2015-05-30       Impact factor: 3.500

8.  Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo.

Authors:  L Wang; I Vuletic; D Deng; W Crielaard; Z Xie; K Zhou; J Zhang; H Sun; Q Ren; C Guo
Journal:  Gene Ther       Date:  2017-08-14       Impact factor: 5.250

Review 9.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

10.  Electrostatic Interactions and Protein Competition Reveal a Dynamic Surface in Gold Nanoparticle-Protein Adsorption.

Authors:  Ailin Wang; Y Randika Perera; Mackenzie B Davidson; Nicholas C Fitzkee
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2016-10-05       Impact factor: 4.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.